Patent · US Active

Solubilizing of metronidazole

US7981916B2 · kind B2 · utility

5Cited by

3References

21Claims

0Family size

Assignee

Galderma Holding SA · CH

Inventors

Claire Mallard · Mougins, FR
Alain Brzokewicz · Valbonne, FR

Key dates

Filing date	Dec 17, 2007
Grant date	Jul 19, 2011
Priority date	—
Expiry date	Jan 4, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/122
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Metronidazole is solubilized in an aqueous phase, by mixing same with niacinamide and at least two glycolic cosolvents; the resulting solutions and pharmaceutical compositions comprised thereof are useful for the treatment of dermatological conditions/afflictions, notably rosacea.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.